Outcomes of neoadjuvant chemotherapy with FOLFOX/FOLFIRINOX and chemoradiotherapy in borderline resectable pancreatic cancer: Single-institution experience Article
Full Text via DOI: 10.1200/jco.2014.32.3_suppl.327
Web of Science: 000333682100328